Right in the middle of the map emerging between Ron Davis and Bruce Wooley (see
previous post), we see Helmy Eltoukhy. Dr. Eltoukhy's PhD advisor was Dr. El Gamal.
Helmy Eltoukhy has gone on to become a serial entrepreneur and pioneer in the biotech industry. After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) in 2006 to work on low-cost DNA sequencing technologies. At SGTC, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-gen sequencing. In 2007, he co-founded Avantome to commercialize a low-cost, high-performance next-gen sequencing platform to seed the democratization of next-gen sequencing. As its founding CEO, he led Avantome through two rounds of financing and through acquisition by Illumina in 2008. At Illumina, Helmy was Sr Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems.
Dr. Eltoukhy (PhD '06) has now partnered with Dr. Amir Ali Talasaz to launch another company,
Guardant Health to apply next-generation DNA sequencing technology to cancer detection. Does this widget convey the pedigree of this collaboration? We see two experienced entrepreneurs, recent patents, and a prior company sold to Illumina. Click on the image below to explore the widget.